1. Introduction {#s0005}
===============

Tuberculosis (TB) is one of the most infectious deadly diseases. The main aetiology of *Mycobacterium tuberculosis* (MTB) infection can occur in anyone without distinction amongst sex, age or localisation ([@b0045], [@b0065], [@b0775]). In 1993, the World Health Organisation (WHO) declared TB as a public health emergency ([@b0015], [@b0750]). Even though TB is endemic in all countries worldwide, in developing countries, it is more likely to cause deaths than other infectious diseases ([@b0065], [@b0360]). The WHO reported numerous deaths due to TB in 2018; approximately 1.2 million (1.1--1.3 million) out of the 10.0 million (9.0--11.1 million) people afflicted with this disease are found in endemic countries. In 2018, 53,620 cases of TB were identified in the Middle Eastern and North African (MENA) region; most of these cases were detected in three countries, namely, Iraq, Egypt and Sudan ([@b0950]). The MENA region includes the following countries: Algeria, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Malta, Morocco, Oman, Qatar, Saudi Arabia, Syria, Tunisia, Turkey, United Arab Emirates, Palestine, Yemen, Ethiopia and Sudan; all of these countries have a long history of plant use for traditional medicine ([@b0145]). The estimated incidences of TB in the MENA region vary due to gaps in case detection because of under-reporting and under-diagnosis ([@b0060]).

TB is a public health problem that mainly affects the respiratory system, primarily the lungs; however, it can also infect other systems and organs, such as the reproductive system ([@b0890]). Chemotherapy drugs, like rifampicin and isoniazid, are used to treat infectious TB diseases and are the first line of defence against this disease. Other chemical-based drugs include ethambutol and pyrazinamide, which have adverse effects. Failure to adhere to treatment through the irregular and noncontinuous use of medication results in bacterial resistance. As a result, a patient may be at risk of developing multidrug-resistant TB within a year of treatment. TB drugs with high side effects and low activity include amikacin, capreomycin, streptomycin and fluoroquinolones ([@b0045], [@b0215], [@b0585]). Drug-resistant TB can be classified into two types: multidrug resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB). Approximately 4% of patients with TB worldwide are suffering from MDR-TB strains that resist standard first-line TB drugs; XDR-TB occurs when bacterial strains are resistant to all first-line and second-level TB drugs ([@b0370], [@b0455], [@b0835]).

The 2014 WHO report on MDR-TB and XDR-TB screening discovered approximately 480,000 cases of MDR-TB in different locations worldwide; more than half of these cases are found in India, China and the Russian Federation, with the highest number of cases of MDR-TB recorded in China ([@b0365], [@b0485]). The disadvantages of chemotherapy have motivated researchers and doctors to use medicinal plants and traditional medicine to treat infectious and chronic diseases, such as TB ([@b0500]). The actual need to resolve chemotherapy drawbacks has resulted in the search for new, easily obtainable solutions with good activity against MTB strains and few disadvantages ([@b0185], [@b0765]). Medicinal plants have been used in many different fields, and many have been comprehensively investigated ([@b0385], [@b0525]). Approximately 75% of the world population uses medicinal plants for traditional treatment and healthcare for different diseases ([@b0515]).

In 2007, Gautam et al. reviewed different families of medicinal plants from India with potential anti-TB activities and identified 25 species with the highest anti-TB activity ([@b0375]). Many medicinal plants from different families have been found to have activity against TB ([@b0415]). Recent reviews published in 2016 focused on anti-TB medicinal plants that originated from different locations, such as Africa, Asia, Europe, South America and Canada; several of these medicinal plant species exhibit putative antimycobacterial activity and yielded numerous bioactive compounds ([@b0220]). Several anti-TB plants from Southeast Asia have been reviewed by Sanusi. Most recent reviews described anti-TB natural products based on medicinal plants with activities of 0--\<10 µg/ml in their crude or pure forms ([@b0805]).

Another review article reported that in Northern Iraq, 63 medicinal plants are used to treat 99 different types of diseases ([@b0055]). Some medicinal plants from Turkey, particularly one member of the mint family that contains different phytochemicals, such as flavonoids, phenolics and other ingredients, have shown good results in the treatment of TB ([@b0130]). All previous reviews included scientifically reviewed studies that focused on plants that are used as traditional medicine against respiratory disease problems and are sourced from the MENA region ([@b0055], [@b0825]). The many traditional uses of plants from the MENA region are listed in [Table 1](#t0005){ref-type="table"}.Table 1MENA region medicinal plants with antimycobacterial activity.Plant FamilyBotanical NameEnglishnamelocationPart used: Preparation Extract / Active CompoundMode of Action**Local medicinal uses**Acanthaceae*Adhatoda vasica* Nees LArushaEgyptLeaf: methanol extractThe methanol extract of leaf exhibited activity against *M. bovis* BCG at MIC of \>500 µg/mL ([@b0030]).Colds, cough ([@b0690], [@b0800]).Apiaceae*Apium graveolens*CeleryIraqEthanol extract 70%Ethanol extract of plant showed activity at 200 mg/ml concentration and growth MTB 20 colonies in 4 week incubation ([@b0010]).Nil*Cuminum cyminum* L.PeanutIraqEthanol extract 70%The crude plant extract was active at 200 mg/ml concentration and showed no growth MTB ([@b0010])Antibacterial ([@b0700])*Pimpinella anisum*FlaxIraqEthanol extract 70%At 200 mg/ml, the plant crude extract showed activity against MTB and 3 colonies presented after 4 week incubation time ([@b0010]).NilApocynaceae*Nerium oleander* L.OleanderEgyptLeaf: methanol extractThe methanol extract of leaf exhibited activity against *M. bovis* BCG at MIC of \>500 µg/mL ([@b0030]).Antibacterial([@b0440])*Thevetia neriifolia* Juss ex ADC.Yellow oleanderEgyptLeaf: methanol extractMethanol extract of leaf plant showed inhibition against *M. bovis* BCG at MIC of \>500 µg/mL ([@b0030]).Antibacterial, insecticides([@b0165], [@b0510])Asphodelaceae*Aloe. vera*Aloe perfoliataIranAqueous extractsThe extract inhibit cell growth activity at 1 mg/mL concentration by time kill 95% in 1 week and 60 mm inhibition zone by disk diffusion method ([@b0090]).Skin treatment ([@b0755]).Asteraceae*Ambrosia maritima* L.RagweedsEgyptLeaf : methanol extractThe extract was active against *M. bovis* BCG at MIC 250 µg/mL ([@b0030]).Nil*Centaurea depressa* Bieb.knapweedTurkeyAerial: ethanol extracts 70%The ethanol crude extract exhibited activity against growth H37Rv strain at concentrations 100 µg/ml with MIC 6% ([@b0905]).Anti-inflammatory ([@b0250]).*Cichorium intybus* LChicoryEgyptHerb: methanol extractThe plant crude extract showed activity against *M. bovis* BCG at MIC \> 500 µg/mL ([@b0030]).Local food & plants in Europe ([@b0450]).*Echinops purgens* Trautv.ThistlesTurkeyAerial: ethanol extracts 70%At 100 µg/ml of the ethanol extract showed 21% Inhibition of growth against H37Rv ([@b0905]).Antipyretic ([@b0635]).*Helianthus annuus* L.SunflowerTurkeyLeaf: ethanol extracts 70%Crude plant extract was active against growth of H37Rv strain at 100 µg/ml with MIC 35% ([@b0905]).Antibacterial ([@b0410]).*Helianthus annuus* L.SunflowerEgyptFlower: methanol extractThe methanol flower extract was active against *M. bovis* BCG at MIC \> 500 µg/mL ([@b0030]).Antibacterial ([@b0410]).*Helichrysum plicatum* DC. subsp. pseudoplicatum (N;ab.)AltınotuTurkeyAerial: ethanol extracts 70%Arial ethanol plant extract showed activity against growth of H37Rv strain at concentrations \>100 µg/ml with MIC 8% ([@b0905]).Cough ([@b0965]).*Inula helenium* L. subsp. *turcoracemosa*Horse-healTurkeyRoot: maceration by ethanol extracts 70%, fractionation by with petroleum ether, chloroform, methanol and water/AlantolactoneThe crude ethanol extract exhibited activity against H37Rv strain at MIC \< 100 µg/ml with MIC 100% Inhibition activity. The fractionation and isolation compound have been screening against *M. tuberculosis* H37Rv and showed activity at MICs 3.125 µg/ml ([@b0905]).Nil*Inula peacockiana* (Aitch. et Hemsl.) KrovinNilTurkeyAerial: ethanol extracts 70%The plant crude extract showed activity against H37Rv at concentrations \>100 µg/ml with MIC 6% ([@b0905]).Expectorant ([@b0395]).*Jasonia candicans*(Delile)BotschCandicansEgyptAerial part: maceration with 70% methanolMethanol extracts of plant showed activity against the *M. phlei, M. smegmatis* and *M. tuberculosis* H37Rv with MIC 1.95, 6.25 and 7.8 mg/ml & DIZ 27,29 and17 mm, respectively ([@b0785]).Antitussive & antimicrobial ([@b0230]).*Onopordum acanthium* LScotchEgyptRoots: maceration with 70% methanolThe root plant extracts showed activity against *M. phlei, M. smegmatis* and *M. tuberculosis* H37Rv with MIC 15.6, 25 and 62.5 mg/ml & DIZ 15.5, 25 and 13 mm, respectively ([@b0785]).Antiseptic ([@b0785]).*Onopordum anatolicum* (Boiss.) EigKoufotiTurkeyAerial: ethanol extracts 70%The extract exhibited activity against H37Rv at concentrations \>100 µg/ml with MIC 22% ([@b0905]).Nil*Pulicaria gnaphalodes*False fleabaneIranLeaves, stem and flower: hydro-distillation waterAt 640 µg/ml, the oil plant parts extract showed activity against H37RV and MTB sensitive isolates and observed 58.1% inhibition percentage ([@b0460]).Allopathic potential ([@b0150]).*Sonchus oleraceus* L.Sow thistleEgyptFlower: methanol extractMethanol flower extract exhibited activity against *M. bovis* BCG at MIC \> 500 µg/mL ([@b0030]).Cough &asthma ([@b0925]).*Tagetes patula* L.Mexican marigoldEgyptFlower: methanol extractThe flower extract showed activity at MIC \> 500 µg/mL against *M. bovis* BCG ([@b0030]).Antifungal ([@b0265]).*Tanacetum sinaicum* Delile ex DC.EgyptFlower: methanol extractThe crude extract was active against *M. bovis* BCG at MIC \> 500 µg/mL ([@b0030]).Antimicrobial ([@b0625]).*Tripleurospermum conoclinium* (Boiss. et Ball.) HayekMayweedTurkeyAerial: ethanol extracts 70%At 100 µg/ml, crude plant extract exhibited 95% inhibition activity against growth of H37Rv ([@b0905]).Asthma &cold ([@b0820]).Balanitaceae*Balanites aegyptiaca*(L.) Del.Desert dateSudanLeaf, bark and root: sonication dichloromethane, ethyl acetate and ethanol (10 mg/ml)The plant parts extract exhibited strong activity against *Mycobacterium aurum* A^+^ ([@b0280]).Headache& cough ([@b0085]).Berberidaceae*Mahonia aquifolium* (Pursch.) NuttOregon GrapeTurkeyBranches, leaves and flowers : ethanol extracts 70%All the parts ethanol extraction showed activity against H37Rv at concentration 100 µg/ml with 49% Inhibition percentage ([@b0905]).Fever& diarrhea ([@b0445]).Bignoniaceae*Kigelia Africana*(Lam.) Benth.KigeliaSudanLeaf, bark: sonication dichloromethane, ethyl acetate and ethanol (10 mg/ml)The plant parts extract exhibited activity against *Mycobacterium aurum* A^+^ at different concentration ([@b0280]).Skin fungal infections ([@b0790])Boraginaceae*Anchusa azurea* Miller var. azureaNilTurkeyAerial: ethanol extracts 70%At 100 µg/ml, the ethanol plant extract showed 35% inhibition of growth against H37Rv ([@b0905]).Anti-inflammatory ([@b0575]).*Cerinthe minor* L. auriculata (Ten.) DomacHoneywortsTurkeyAerial: ethanol extracts 70%The crude extract exhibited activity against H37Rv at 100 µg/ml with inhibition growth 18% ([@b0905]).Cough ([@b0545]).*Echium Plantagineum* L.Purple viper\'s-buglossTurkeyAerial: ethanol extracts 70%The crude extract exhibited Inhibition against H37Rv at concentrations 100 µg/ml with 65% inhibition growth ([@b0905]).Colds, coughs and fever ([@b0530]).*Echium italicum* L.Lady Campbell weedTurkeyAerial: ethanol extracts 70%The plant extract exhibited activity against growth of H37Rv strain at concentrations 100 µg/mL with MIC 37% inhibition growth ([@b0905]).Wound healing ([@b0080]).*Heliotropium dolosum* De Not.HeliotropeTurkeyAerial and seeds: ethanol extracts 70%At 100 µg/ml, the ethanol extract showed 4% & 85% inhibition against growth of H37Rv strain, respectively ([@b0905]).Cough and treat wounds ([@b0665], [@b0770]).*Moltkiopsis ciliata*(Forssk.)I.MNilEgyptAerial part: maceration with 70% methanolThe crude extracts was activate against the *M. phlei M. smegmatis* and *M. tuberculosis* H37Rv at MIC 40, 10 and7.8 mg/ml & DIZ 26, 22 and 17 mm, respectively ([@b0785]).Cough, wound healing ([@b0070], [@b0785]).*Myosotis olympica* Boiss.forget-me-notsTurkeyAerial: ethanol extracts 70%The ethanol extract at concentration of 100 µg/ml showed 14% inhibition against H37Rv strain ([@b0905]).NilBrassicaceae*Alyssum fulvescens* Sibth. et Sm. var. fulvescensSweet alyssumTurkeyAerial: ethanol extracts 70%At 100 µg/ml, the ethanol extract showed anti-TB activity against H37Rv with 1% inhibition growth ([@b0905]).Nil*Cheiranthus cheiri* L.WallflowerTurkeyAerial: ethanol extracts 70%At 100 µg/ml, the ethanol extract showed activity against H37Rv with 13% inhibition growth ([@b0905]).Dry bronchitis ([@b0310]).*Crambe orientalis* L.CrambeTurkeyAerial: ethanol extracts 70%The ethanol plant extract showed activity against H37Rv at 100 µg/ml with 21% inhibition growth ([@b0905]).Industrial herbs ([@b0745]).*Erysimum cuspidatum* (Bieb.) DCNilTurkeyAerial: ethanol extracts 70%At 100 µg/ml, was active against H37Rv strain with 55% Inhibition of growth ([@b0905]).Nil*Isatis microcarpa*J. Gay ex Boiss.NilEgyptWhole plant: maceration with 70% methanolMethanol extracts of whole plant showed activity against *M. phlei M. smegmatis* and *M .tuberculosis* H37Rv strain with MIC 50, 12.5 and 62.5 mg/ml & DIZ 18, 20 and 12 mm, respectively ([@b0785]).Nasal infections &cold ([@b0785]).*Lepidium sativum*CuminIraqEthanol extract 70%The ethanol extract at 200 mg/ml was active with no growth against MTB ([@b0010]).Nil*Lepidium vesicarium* L.CruciferaeTurkeyAerial: ethanol extracts 70%The crude plant extract exhibited against growth H37Rv at 100 µg/ml with 3% Inhibition of growth ([@b0905]).Antimicrobial ([@b0190]).*Moricandia nitens*(Viv) E.A.Durand&BarratteViolet cabbageEgyptAerial part: maceration with 70% methanolThe extract showed activity against the *M. phlei M. smegmatis and M. tuberculosis* H37Rv with MIC 31.3, 25 and 125 mg/ml & DIZ 15, 25 and 10 mm, respectively ([@b0785]).Bacterial infectious ([@b0230]).*Nasturtium africanum*(Braun-Blanq)Moroccan watercressEgyptAerial part: maceration with 70% methanolMethanol extracts methanol of plant exhibited activity against *M. phlei* at MIC of 80 mg/ml & DIZ 26 mm ([@b0785]).Bronchitis ([@b0785]).*Raphanus raphanistrum* L.Wild radishTurkeyAerial: ethanol extracts 70%The aerial ethanol extract at concentrations 100 µg/ml showed 19% Inhibition of growth against H37Rv strain ([@b0905]).Anti-rheumatic &antioxidant ([@b0560]).Burseraceae*Boswellia papyrifera* (Del) Hochst olibanumOlibanumSudanhydro-distillation /1)Octyl acetate 37.26%2)Octyl formate 13.25%3)verticilla-4(20),7,11-triene 6.85%The oils extract with isolated compound (1,2 and 3) all was active against nine clinical isolates and H37Rv of *tuberculosis* at 15 μl/ml ([@b0285]).Antibacterial, diarrhea ([@b0025], [@b0140]).*Boswellia serrata*FrankincenseIranPowder: percolation extraction 80% ethanolThe plant crude extract showed activity result against *M. bovis* at 125.0 μg/ml ([@b0730]).Anti-inflammatory ([@b0555], [@b0715]).*Commiphora molmol*MyrrhIraqEthanol extract 70%Ethanol extract at 200 mg/ml concentration exhibited activity with no growth against MTB ([@b0010]).Antibacterial ([@b0020]).Capparaceae*Capparis spinosa* L.CaperIranFruits: methanol extractionAt 25 mg/mL, the methanol extract of the fruit was activate against seven clinical samples & H37Rv strain ([@b0270]).Antibacterial ([@b0270]).Capparidaceae*Capparis decidua*(Forssk.) Edgew.KariraSudanTwigs and root: Sonication dichloromethane, ethyl acetate and ethanol (10 mg/ml)The plant extract exhibited activity against *Mycobacterium aurum* A^+^ with (MIC) values\
Twigs extract 12.5, 25 & 6.25 mg/ml\
Root extract 25, na & 6.25 mg/ml\
([@b0280]).Asthma ([@b0850]).Caryophyllaceae*Silene arguta* Fenzl.GivisganotuTurkeyAerial: ethanol extracts 70%At 100 μg/ml, the plant extract showed activity against H37Rv with 24% Inhibition of growth ([@b0905]).Nil*Silene chlorifolia* Sm.NilTurkeyAerial: ethanol extracts 70%The extract at concentrations 100 μg/ml exhibited anti-TB activity against growth H37Rv with 10% Inhibition of growth ([@b0905]).Antimicrobial &antifungal ([@b0610]).*Silene dichotoma* Ehrh. subsp. sibthorpiana (Reichb.) RechForked catchflyTurkeyAerial: ethanol extracts 70%Ethanol extract at 100 μg/ml concentrations showed activity 42% Inhibition of growth against H37Rv strain ([@b0905]).Cold & cough ([@b0210]).*Silene vulgaris* (Moench) Garcke var. commutata (Guss.)Coode et CullenBladder campionTurkeyAerial: ethanol extracts 70%The crude extract exhibited anti-TB activity against H37Rv at concentrations 100 μg/ml with 30% Inhibition of growth ([@b0905]).Cold & cough ([@b0210]).Chenopodiaceae*Spinacia oleracea* L.SpinachTurkeyLeaves: ethanol extracts 70%The extraction showed activity against H37Rv at concentrations of 100 μg/ml with 81% Inhibition of growth ([@b0905]).Asthma ([@b0350]).Cistaceae*Cistus laurifolius* L.Laurel-leaf cistusTurkeyAerial: ethanol extracts 70%At 100 μg/ml, the plant extract showed activity against H37Rv with 34% Inhibition of growth ([@b0905]).Antibacterial, antifungal ([@b0050], [@b0225]).Combretaceae*Combretumhartmannianum* Schweinf.NilSudanLeaf, bark and root: Sonication dichloromethane, ethyl acetate and ethanol (10 mg/ml)The plant parts extract exhibited activity against *Mycobacterium aurum* A^+^ at different concentration ([@b0280]).NilConvolvulaceae*Calystegia silvatica* (Kit.) Griseb.Giant bindweedTurkeyAerial: ethanol extracts 70%At 100 μg/ml, the plant extract showed activity against H37Rv with 69% Inhibition of growth([@b0905]).Herbicides ([@b0380]).Crassulaceae*Sedum stoloniferum* GmeliStonecropsTurkeyAerial: ethanol extracts 70%The extract at concentration of 100 μg/ml exhibited anti-TB activity against growth H37Rv with 21% Inhibition of growth ([@b0905]).Antioxidative ([@b0435]).Crucifereae*Nasturtium officinale* R.BrWatercressEgyptSeed: methanol extractMethanol extract of seed showed activity against *M. bovis* BCG at MIC 500 μg/ml ([@b0030]).Asthma & expectorant ([@b0480]).Cyperaceae*Cyperus esculentus* E. MeyChufa sedgeEgyptSeed: methanol extractThe crude extract showed activity against *M. bovis* BCG at MIC \> 500 μg/ml ([@b0030]).Antimicrobial ([@b0355]).Elaeagnaceae*Elaeagnus angustifolia* L.Russian OliveTurkeyFruits, leaves: ethanol extracts 70%At 100 μg/ml, the plant extract showed activity against H37Rv with 4% Inhibition of growth ([@b0905]).Arthritis ([@b0695]).Euphorbiaceae*Euphorbia paralias* LSea spurgeEgyptWhole plant: maceration withPetroleum ether, Chloroform, Ethyl acetate, Methanol and70% methanol /1)Quercetin 3-O-glucosideThe plant fractionation by methanol showed activity against the *M. phlei M. smegmatis and M. tuberculosis* H37Rv with MIC 5.0, 2.5 and 3.12 mg/ml while DIZ 27.7, 28.3 and 18.0 mm respectively ([@b0785]).\
N10 isolated active compound showed activity against the *M. phlei M. smegmatis and M. tuberculosis* H37Rv with MIC 0.078, 0.312 and 0.15 mg/ml while DIZ 28.5, 25 and 27 mm respectively, with glutamine synthetase enzyme inhibition activity ([@b0785]).Treat asthma, bronchitis. Used as expectorant ([@b0785]).Fabaceae*Arachis hypogaea*PeanutIraqEthanol extract 70%The extract at concentration of 200 mg/ml was active and has no growth against MTB ([@b0010]).NilFagaceae*Quercus robur* L.English oakEgyptFruit: methanol extractThe methanol extract of fruit exhibited activity against *M. bovis* BCG at MIC \> 500 μg/ml ([@b0030]).Asthma ([@b0915]).Geraniaceae*Geranium asphodeloides* Burm. FilNilTurkeyAerial: ethanol extracts 70%At 100 μg/ml, the ethanol extract of plant showed 12% Inhibition growth against H37Rv strain ([@b0905]).Cooked with vegetables ([@b0535]).*Geranium divaricatum* Ehrh.Rose-scented geraniumTurkeyAerial: ethanol extracts 70%The extract at concentrations 100 μg/ml exhibited activity against growth H37Rv with 19% Inhibition of growth ([@b0905]).Relives pain ([@b0405]).*Geranium robertianum* L.Herb robertTurkeyAerial: ethanol extracts 70%Ethanol extract of plant showed activity against H37Rv at concentrations of 100 μg/ml with MIC 10% Inhibition of growth ([@b0905]).Anti-hyperglycaemiant ([@b0335]).Hypericaceae*Hypericum triquetrifolium* TurraNilTurkeyAerial: ethanol extracts 70%At 100 μg/ml, the ethanol extract of plant showed activity against *M. tuberculosis* H37Ra ([@b0900]).Nil*Hypericum perforatum* L.StJohn\'s wortIranAqueous extractsThe extract showed Inhibit cell growth activity at 1 mg/mL concentration by time kill 95% in 1 week and 60 mm inhibition zone by disk diffusion method ([@b0090]).Snake bite, antimicrobial ([@b0100], [@b0840]).Iridaceae*Crocus ancyrensis* (Herbert) MawAnkara crocusTurkeyFlowers: ethanol extracts 70%The extract at concentration of 100 μg/ml exhibited activity against growth H37Rv with 30% inhibition of growth ([@b0905]).Analgesic ([@b0660]).Juglandaceae*Juglans regia* L.WalnutTurkeyLeaves; ethanol extracts 70%The leaves plant extraction was active at 100 μg/ml and showed 12% inhibition of growth against H37Rv ([@b0905]).Asthma ([@b0870]).Juncaceae*Juncus acutus* L.Spiny rushEgyptHerb: methanol extractMethanol extract of herbal exhibited activity against *M. bovis* BCG at MIC \> 500 μg/ml ([@b0030]).Cold ([@b0305]).Labiatae*Rosmarinus officinalis* L.RosemaryEgyptMethanol extractAt \> 500 μg/mL, the methanol plant extract showed activity against *M. bovis* BCG ([@b0030]).Antimicrobial ([@b0195]).Lamiaceae*Saliva tomentosa* Mill.MintTurkeyAerial part: methanol extract 98%/1)Rosmarinic acid2)Catechin3)RutinMethanol extract and selected bioactive compound (1,2 and 3) showed activity against H37Ra at MIC 196 µg**/**mL by MGIT fluorometric test tube ([@b0120]).Colds & antifungal ([@b0710]).*Saliva tomentosa* Mill.MintTurkeyAerial part: Hydro-distillation /1)a-Pinene2)1,8-cineole3)Camphor4)BorneolThe essential oil extraction with all bioactive compound (1, 2, 3 and 4) showed activity against *M. tuberculosis* H37Ra at MIC 196 µg**/**mL by MGIT fluorometric test tube ([@b0110]).Colds & antifungal ([@b0710]).*Saliva fruticosa* Mill.Greek sageTurkeyAerial part: methanol extract 98%1)Caffeic acid2)Rosmarinic acid3)Apigenin4)CarvacrolMethanol extract and selected bioactive compound exhibited activity against H37Ra at MIC 392 μg/mL by MGIT fluorometric test tube ([@b0120]).Colds & antifungal ([@b0710]).*Saliva aucheri* Bentham subsp. *aucheri*NilTurkeyAerial part: Hydro-distillation /1)1,8-cineole2)CamphorThe essential oil extract with bioactive compounds (1 and 2) showed activity against *M. tuberculosis* H37Ra at MIC 196 µg**/**mL by MGIT fluorometric test tube ([@b0110]).Nil*Saliva verticiilata* L. subsp. *amasiaca*Hooked bristlegrassTurkeyAerial part: Hydro-distillation /1)ß-Pinene2)1,8-cineoleThe essential oil extract with bioactive compounds (1 and 2) was active against *M. tuberculosis* H37Ra at MIC 196 µg**/**mL by MGIT fluorometric test tube ([@b0110]).Colds, antibacterial([@b0110], [@b0855]).*Saliva. kronenburgii* Rech.NilTurkeyAerial: ethanol extracts 70%At 100 μg/ml, the ethanol extract of plant showed activity against *M. tuberculosis* H37Ra ([@b0900]).Nil*Sideritis albiflora*Mountain teaTurkeyAerial part: methanol extract 98%1)Caffeic acid2)Rosmarinic acid3)CarvacrolThe whole plant extract with active compound showed activity against H37Ra at MIC 1568 μg/mL by MGIT fluorometric test tube ([@b0120]).Nil*Sideritis leptoclada*Mountain teaTurkeyAerial part: methanol extract 98%1)Caffeic acid2)Rosmarinic acid3)RutinThe methanol extract showed activity against H37Ra at MIC 1568 μg/mL by MGIT fluorometric test tube ([@b0120]).Nil*Perovskia abrotanoides* Kar.Russian SageIranLeaves, stem, and flower: hydro-distillationThe plant oil extract showed activity against H37RV and MTB sensitive isolates at MIC 640 μg /ml and observed 76.2% inhibition percentage ([@b0460]).Antiseptic, antibacterial. ([@b0180], [@b0670]).*Mentha spicata*SpearmintIranPowder: percolation extraction 80% ethanolAt 0.39 mg/ml, the ethanol extract showed activity against *M. bovis* ([@b0605]).Nil*Mentha piperta*PeppermintIranPowder: percolation extraction 80% ethanolThe extract was active against *M. bovis* at 100 mg/ml ([@b0605]).Antibacterial activity ([@b0895]).*Dracocephalum kotschyi*ZarringiahIranLeaves: maceration methanol 70%The methanol extract exhibited activity against H37Rv at 640 μg/mL concentration ([@b0105]).Anti-spasmodic, analgesic, anti-parasite ([@b0400], [@b0780])*Lavandula stoechas*LavenderIranPowder: percolation extraction 80% ethanolEthanol extract of plant powder showed activity against *M. bovis* at 250 μg/ml ([@b0730]).Antimicrobial ([@b0920]).*Rosmarinus officinalis*RosemaryIranPowder: percolation extraction 80% ethanolThe extract at concentration 187.5 μg/ml, was active against *M. bovis* ([@b0730]).Antimicrobial ([@b0160], [@b0685]).*Thymus vulgaris*Garden ThymeIranPowder: percolation extraction 80% ethanolThe plant extract showed activity against *M. bovis* at 500.0 μg/ml ([@b0730]).Antibacterial, antifungal ([@b0650], [@b0720]).*Thymus vulgaris*Garden ThymeIranLeaves: hydro- distillation processThe essential oil showed strong activity against clinical isolate *M. tuberculosis* and H37Rv stander strain at below 40 μg/ml ([@b0720]).Antibacterial, antifungal ([@b0650], [@b0720]).MintMintIranAqueous extractsAqueous extract of plant inhibit mycobacterium growth activity at 1 mg/mL concentration by time kill 95% in 1 week ([@b0090]).Nil*Thymus sibthorpii* Benth.ThymusTurkeyAerial part: maceration by petroleum ether, ethyl acetate, methanol and fraction:1)Rosmarinic acid2)Caffeic acidThe petroleum ether fraction was active against *M. tuberculosis* H37Rv and H37Ra with MIC of 12.5 and 50 μg/ml concentration respectively.\
The ethyl acetate fractions showed activity against *M. tuberculosis* H37Rv and H37Ra with MIC of 12.5 μg/ml concentration. The MBC value of 50--800 μg/ml ([@b0135]).Antiseptic agent ([@b0135]).*Satureja aintabensis* P.H. DavisSavoryTurkeyAerial part: maceration by petroleum ether, ethyl acetate, methanol and fraction:1)Rosmarinic acid2)Naringenin3)Hesperidin4)Luteolin5)Caffeic acidThe petroleum ether fraction was active against *M. tuberculosis* H37Rv and H37Ra with MIC of 25 and 50 μg/ml concentration respectively.\
The ethyl acetate fractions showed activity against *M. tuberculosis* H37Rv and H37Ra with MIC of 12.5 μg/ml concentration. The MBC value of 50--100 μg/ml against four tested organism ([@b0135]).Antifungal, antibacterial ([@b0115], [@b0245]).*Micromeria juliana* (L.) Benth. ex ReichMerisTurkeyAerial part: maceration by petroleum ether, ethyl acetate, methanol and fraction:1)Rosmarinic acid2)Chlorogenic acid3)Rutin hydrate4)Caffeic acidThe ethyl acetate fractions was active against *M. tuberculosis* H37Rv and H37Ra with MIC of 100 and 50 μg/ml concentration respectively ([@b0135]).Tonsillitis and common cold ([@b0135]).*Ballota acetabulosa* (L.) BenthNilTurkeyAerial part: maceration by petroleum ether, ethyl acetate, methanol and fractionThe petroleum ether fraction showed activity against *M. tuberculosis* H37Rv and H37Ra with MIC of 200 and 400 μg/ml concentration respectively. The MBC value of 800 μg/ml ([@b0135]).Cough ([@b0135]).*Thymbra spicata* L. var. *spicata*KekikTurkeyAerial parts: methanol extracts (98%)/1)Carvacrol2)Rosmarinic acid3)Hesperidin4)NaringeninAt 196 μg/ml, the methanol extract exhibited high level of activity against *M. tuberculosis* H37Ra by MGIT indicator tubes ([@b0125]).Antimicrobial ([@b0865]).*Origanum minutiflorum* O.Schwarz and P.H. DavisEndemicTurkeyAerial parts: methanol extracts (98%)/1)Carvacrol2)Rosmarinic acid3)Eriodictiol4)LuteolinThe methanol plant extract with active compound was active against *M. tuberculosis* H37Ra with MIC 392 μg/ml concentration by MGIT indicator tubes ([@b0125]).Antibacterial ([@b0235]).*Clinopodium vulgare* L. subsp. arundanum(Boiss.) NymanWild basilTurkeyAerial: ethanol extracts 70%The crude plant extract showed inhibition against H37Rv extract at concentrations 100 μg/ml with 12% ([@b0905]).Anti-inflammatory ([@b0175]).*Eremostachys laciniata* (L.) BungeBungeTurkeyAerial: ethanol extracts 70%The plant extraction showed Inhibition of growth H37Rv at concentrations 100 μg/ml with 54% ([@b0905]).Headaches ([@b0430]).*Lamium purpureum* L.Red deadnettleTurkeyAerial: ethanol extracts 70%At 100 μg/ml, plant ethanol extract showed 48% inhibition against H37Rv ([@b0905]).Fracture ([@b0955]).*Lavandula stoechas* L. subsp. cariensis (Boiss.) RozeiraFrench lavenderTurkeyAerial: ethanol extracts 70%The ethanol extract showed 17% Inhibition of growth against H37Rv at 100 μg/ml ([@b0905]).Nil*Marrubium parviflorum* Fisch. et Mey. subsp. oligodon(Boiss.) SeyboldHorehoundTurkeyAerial: ethanol extracts 70%At 100 μg/ml, plant ethanol extract showed 3% inhibition against H37Rv ([@b0905]).Nil*Mentha longifolia* (L.) Hudson subsp. longifoliaHorse mintTurkeyAerial: ethanol extracts 70%The crude plant extract showed activity against H37Rv at concentrations 100 μg/ml with 33% inhibition ([@b0905]).Antispasmodic ([@b0640]).*Phlomis lunariifolia* Sm.Jerusalem sageTurkeyAerial: ethanol extracts 70%At 100 μg/ml, the extract of plant was active against H37Rv with 8% Inhibition of growth ([@b0905]).Nil*Rosmarinus officinalis* L.NilTurkeyLeave and flower: ethanol extracts 70%The extract at concentrations 100 μg/ml showed 66% Inhibition of growth against H37Rv strain ([@b0905]).Nil*Sideritis libanotica* Labill. subsp. linearis(Bentham) Bornm.Mountain teaTurkeyAerial :ethanol extracts 70%Ethanol extract showed activity against of growth H37Rv at concentrations 100 μg/ml with 4% Inhibition of growth ([@b0905]).Nil*Teucrium parviflorum* SchreberGermandersTurkeyAerial: ethanol extracts 70%The crude plant extract showed activity against H37Rv at concentrations 100 μg/ml with 2% inhibition ([@b0905]).Antimicrobial ([@b0910]).*Origanum onites*Pot marjoramTurkeyAerial part: methanol extract 98%1)Rosmarinic acid2)Carvacrol3)ApigeninThe plant methanol extract and all bioactive compound (1, 2 and 3) exhibited activity against H37Ra at MIC 784 μg/mL concentration by MGIT fluorometric test tube ([@b0120]).Colds and sore throat ([@b0120]).*Origanum acutidens*(Hand.-Mazz.) Ietswaart.NilTurkeyAerial parts: sequential extraction method chloroform (CL),ethyl acetate (EA) and methanol (ME)/1)Rosmarinic acid2)Vanillic acidThe crude chloroform, ethyl acetate and methanol extracts of plant have screened against H37Ra with MIC 0.4 mg/mL in chloroform extract ([@b0130]).Colds and sore throat ([@b0120]).*Origanum sipyleum* L.PerennialsTurkeyAerial parts: sequential extraction method chloroform (CL),ethyl acetate (EA) and methanol (ME)/1)Rosmarinic acid2)Rutin hydrate3)Vanillic acidThe crude chloroform, ethyl acetate and methanol extracts of plant have screened against H37Ra with MIC 1.6 mg/mL in ethyl acetate extract ([@b0130]).Antispasmodic & antibacterial ([@b0170]).*Salvia viridis* L.OrvalTurkeyAerial parts: sequential extraction method chloroform (CL),ethyl acetate (EA) and methanol (ME)/1)Rosmarinic acid2)HesperidinThe crude chloroform, ethyl acetate and methanol extracts of plant have screened against H37Ra with MIC 6.3 mg/mL in chloroform extract ([@b0130]).Antimicrobial, common cold, throat infections([@b0760], [@b0875]).*Salvia microstegia*Boiss&Bal.NilTurkeyAerial parts: sequential extraction method chloroform (CL),ethyl acetate (EA) and methanol (ME)/1)Rosmarinic acid2)p-coumaric acid3)LuteolinThe crude chloroform, ethyl acetate and methanol extracts of plant have screened against H37Ra with MIC 0.4 mg/mL in chloroform extract ([@b0130]).Antimicrobial, common cold, throat infections([@b0760], [@b0875]).*Salvia aethiopis* L.NilTurkeyAerial: ethanol extracts 70% and fraction with petroleum ether, chloroform, methanol and waterThe plant extraction and fraction by petroleum ether and chloroform was active at 50 μg/ml MIC against *M.tuberculosis* H37Ra ([@b0900]).Nil*Satureja boissieri* Hausskn.ex Boiss.ThymeTurkeyAerial parts: sequential extraction method chloroform (CL),ethyl acetate (EA) and methanol (ME)/1)Rosmarinic acid2)Naringenin3)HesperidinThe crude chloroform, ethyl acetate and methanol extracts of plant have screened against H37Rv with MIC 0.4 mg/mL in chloroform extract ([@b0130]).Antimicrobial, common cold, throat infections ([@b0760], [@b0875]).*Stachys sylvatica* L.NilTurkeyAerial: ethanol extracts 70% and fraction with petroleum ether, chloroform, methanol and waterThe plant extraction and fraction by petroleum ether showed activity at 50 μg/ml MIC against *M.tuberculosis* H37Ra ([@b0900]).Nil*Stachys byzantine*C.Koch.Lamb\'s-earTurkeyAerial parts: sequential extraction method chloroform (CL),ethyl acetate (EA) and methanol (ME)/1)Rosmarinic acid2)NaringeninThe crude chloroform, ethyl acetate and methanol extracts of plant have screened against H37Ra with MIC 0.8 mg/mL in chloroform extract ([@b0130]).Antimicrobial, common cold, throat infections ([@b0600], [@b0875]).*Stachys cretica* L*.*self-healTurkeyAerial parts: sequential extraction method chloroform (CL),ethyl acetate (EA) and methanol (ME)/1)Rosmarinic acidThe crude chloroform, ethyl acetate and methanol extracts of plant have screened against H37Rv with MIC 6.3 mg/mL in chloroform extract ([@b0130]).Antimicrobial, common cold, throat infections ([@b0600], [@b0875]).*Stachys cretica* subsp.*smyrnaea* Rech*.*fil.betonyTurkeyAerial parts: sequential extraction method chloroform (CL),ethyl acetate (EA) and methanol (ME)/1)Rutin hydrate2)p-coumaric acidThe crude chloroform, ethyl acetate and methanol extracts of plant have screened against H37Ra with MIC 6.3 mg/mL in chloroform extract ([@b0130]).Antimicrobial, common cold, throat infections ([@b0600], [@b0875]).*Thymus syriacus* Boiss.ThymesTurkeyAerial parts: sequential extraction method chloroform (CL),ethyl acetate (EA) and methanol (ME)/1)Rosmarinic acid2)Rutin hydrate3)p-coumaric acidThe crude chloroform, ethyl acetate and methanol extracts of plant have screened against H37Ra with MIC 0.4 mg/mL in chloroform extract and 0.8 mg/mL in ethyl acetate ([@b0130]).Antimicrobial, common cold, throat infections ([@b0600], [@b0875]).*Thymus cilicicus*Boiss&Bal.*(endemic)*ThymesTurkeyAerial parts: sequential extraction method chloroform (CL),ethyl acetate (EA) and methanol (ME)/1)Rosmarinic acid2)Rutin hydrateThe crude chloroform, ethyl acetate and methanol extracts of plant have screened against H37Rv with MIC 6.3 mg/mL in chloroform extract ([@b0130]).Antimicrobial, common cold, throat infections ([@b0600], [@b0875]).*Premna odorata*AlagawEgyptLeaves, young stems, and flowers: hydrodistillation process1)Trans-caryophyllene2)β-phellandrene3)α-pineneThe oil extracted from leaves and young stems parts showed activity. The flowers oils separately with all active compound exhibited clear anti-TB activities with values \>1.5 μg/ml MTB antigen ([@b0295]).Coughs, abdominal pains, fever ([@b0300], [@b0595]).*Rosmarinus officinalis* LRosemarySudanLeaves: Fractionation with water, n-hexane, chloroform, ethanol, ethyl acetate and n-butane.The fractions extract of plant by n-hexane and chloroform was active against MTB H37Ra at 6.25 μg/ml ([@b0040]).Pain ([@b0040]).Lamiaceaea*Phlomis fruticosa* LJerusalem sageEgyptLeaves: maceration with70% methanolMethanol extract showed activity against *M. phlei M. smegmatis* with MIC 25 and 25 mg/ml & DIZ 18.5 and 19 mm, respectively ([@b0785]).Bacterial infections ([@b0230]).LauraceaeCamphoraCubebIraqEthanol extract 70%The ethanol plant extract showed activity at 200 mg/ml against growth MTB and 18 colonies in 4 week incubation time ([@b0010]).Nil*Laurus nobilis* L.Bay laurelTurkeyLeaves : ethanol extracts 70%At 100 μg/ml, the leaves ethanol extract showed 57% Inhibition of growth against H37Rv ([@b0905]).Antimicrobial ([@b0205]).Liliaceae*Veratrum album* L.FalsehelleborineTurkeyLeaves: maceration by ethanol extracts 70%, fractionation by with petroleum ether, chloroform, methanol and water/ jervineThe plant extraction showed activity against H37Rv at concentrations 100 μg/ml with 95% Inhibition of growth\
The chloroform fractions and isolated bioactive compound is jervine have been tested against *M. tuberculosis* H37Rv showed activity with MIC value 50 and 25 μg/ml, respectively. ([@b0905]).NilLinaceae*Linum usitatissumun*CeleryIraqEthanol extract 70%The crude extract showed activity at 0.2 ml/10 ml concentration against growth MTB and 25 colonies in 4 week incubation ([@b0010]).Arthritis ([@b0540]).Magnoliaceae*Magnolia grandiflora* L.Southern magnoliaTurkeyLeaves: ethanol extracts 70%Ethanol extract of the leaves showed 3% inhibition of growth against H37Rv at 100 μg/ml ([@b0905]).Itching ([@b0490]).*Liriodendron tulipifera* L.Tulip treeTurkeyLeaves: ethanol extracts 70%The extract showed activity against H37Rv strain at 100 μg/ml with 77% inhibition ([@b0905]).NilMalvaceae*Hibiscus syriacus* LHibiscusTurkeyArial: ethanol extracts 70%At 100 μg/ml, the leaves ethanol extract showed 22% Inhibition of growth against H37Rv ([@b0905]).Antipyretic ([@b0725]).Meliaceae*Khaya senegalensis*(Desr.) A. Juss.Khaya woodSudanBark: fractionation in water, n-hexane, chloroform, ethanol, ethyl acetate and n-butane.The fractions extract by chloroform, ethanol, ethyl acetate and n-butane was active at 6.25 μg/ml against MTB H37Ra ([@b0040]).Jaundice ([@b0040]).Mimosaceae*Acacia seyal* Del.Vachellia seyalSudanLeaf, bark and root: Sonication dichloromethane, ethyl acetate and ethanol (10 mg/ml)The plant parts extract showed activity with (MIC) values against *Mycobacterium aurum* at different concentration ([@b0280]).Cold ([@b0275]).Moraceae*Ficus carica* L. subsp. caricaCommon figTurkeyleaves: ethanol extracts 70%The extract at concentration of 100 μg/ml showed 1% inhibition against H37Rv ([@b0905]).Asthma and cough ([@b0155]).*Morus alba* L.White mulberryTurkeyleaves: ethanol extracts 70%At 100 μg/ml, the leaves ethanol extract showed 66% Inhibition of growth against H37Rv ([@b0905]).Throat inflammation ([@b0860]).Morinaceae*Morina persica* L.MorinaTurkeyAerial: ethanol extracts 70%The ethanol extract was active against growth of H37Rv at concentrations 100 μg/ml with 5% inhibition ([@b0905]).Antifungal ([@b0680]).Myrtaceae*Eucalyptus camaldulensis*Dehnh leaves,River red gumSudanhydro-distillation /1)1,8-cineole 74.8142)p-Cymene 16.7103)β-Phellandrene 3.990The oils extract showed activity at 15 μl/ml against nine clinical isolates and H37Rv of tuberculosis ([@b0285]).Antifungal ([@b0330], [@b0520]).Nyctaginaceae*Bougainvillea glabra* ChoisyPaper flowerTurkeyLeaves, flower: ethanol extracts 70%Ethanol extract of both leaves and flower at 100 μg/ml showed 24% Inhibition growth against H37Rv ([@b0905]).Analgesic ([@b0005]).Oleaceae*Jasminum officinale* L.Common jasmineTurkeyLeaves, flower: ethanol extracts 70%At 100 μg/ml, the leaves ethanol extract showed 13% Inhibition of growth against H37Rv ([@b0905]).Analgesic ([@b0735]).Onagraceae*Epilobium angustifolium* L.fireweedTurkeyAerial: ethanol extracts 70%The ethanol of plant extract exhibited 7% inhibition against H37Rv at concentrations 100 μg/ml ([@b0905]).NilOrobanchaceae*Cistanche tubulosa*(Schrenk) Hook.fCistanche tubulosaEgyptAerial part: maceration with 70% methanolExtracts showed activity against the *M. phlei M. smegmatis and M. tuberculosis* H37Rv with MIC 62.5, 25 and 125 mg/ml with DIZ 18.5, 20 and 11 mm, respectively ([@b0785]).Antibacterial agent ([@b0230]).Palmae*Hyphaene coriacea* Gaertn.Lala palmEgyptEpicarp and mesocarp : methanol extractThe plant extract was active against *M. bovis* BCG at MIC \> 500 μg/ml ([@b0030]).NilPapaveraceae*Glaucium leiocarpum* Boiss.NilTurkeyAerial : ethanol extracts 70%At 100 μg/ml, the ethanol extract showed 7% Inhibition of growth against H37Rv ([@b0905]).Antimicrobial ([@b0970])*Chelidonium majus* L.NilTurkeyAerial: ethanol extracts 70% and fraction with petroleum ether, chloroform, methanol and waterThe plant extract and fraction inhibited the growth at 50 μg/ml MIC against *M. tuberculosis* H37Ra ([@b0900]).NilPapilionaceae*Erythrina latissima* E.Mey.Deciduous treeSudanBark, root: Sonication dichloromethane, ethyl acetate and ethanol (10 mg/ml)The plant parts extract exhibited result with (MIC) values against *Mycobacterium aurum* A^+^\
Bark extract 1.56, 1.56 & 0.39 mg/ml\
Root extract 0.39, 12.5 &6.25 mg/ml ([@b0280]).Antimicrobial ([@b0945]).Pinaceae*Picea orientalis* (L.) LinkOriental spruceTurkeyWood: ethanol extracts 70%\
Cones: ethanol extracts 70%At 100 μg/ml, the ethanol extract of both wood and cones showed 96% and 26% inhibition of growth against H37Rv, respectively ([@b0905]).Nil*Pinus brutia* Ten.NilTurkeyOleoresin: ethanol extracts 70% and fraction with petroleum ether, chloroform, methanol and waterThe plant extraction and fraction by petroleum ether showed inhibited growth at 50 μg/ml MIC against *M. tuberculosis* H37Ra ([@b0900]).Nil*Pinus nigra* Arn.ssp. *pallasiana* (Lamb.) HolmbaeNilTurkeyCones: ethanol extracts 70%The petroleum ether extract of the plant inhibited the growth of *M. tuberculosis* at concentration of 50 μg/ml ([@b0900])NilPiperaceae*Piper cubeba*Black seedsIraqEthanol extract 70%At 200 mg/ml concentration plant extract showed activity against growth MTB and 15 colonies in 4 week incubation ([@b0010]).Nil*Piper nigrum* LBlack pepperEgyptFruits: maceration with 70% methanolThe methanol extracts of fruits exhibited activity against the *M. phlei* and *M. tuberculosis* H37Rv at MIC 50 and 31.3 mg/ml with DIZ 25 and 11 mm, respectively ([@b0785]).Oral abscesses ([@b0785]).*Piper nigrum* LBlack pepperIraqEthanol extract 70%Ethanol extract showed activity at 200 mg/ml concentration against growth MTB and 4 colonies in 4 week incubation ([@b0010]).Oral abscesses ([@b0785]).Poaceae*Cymbopogen citratus* leavesLemon grassSudanLeaves: hydro-distilled1)citral b (32.74%)2)citral a (26.23%)3)β-pinene (9.36%)Anti-TB activity of essential oils extract at 15 μl/ml against nine clinical isolated *M. tuberculosis* strains and H37Rv ([@b0290]).Antifungal, antibacterial ([@b0630], [@b0650], [@b0930]).*Cymbopogen nervatus* InflorescencesLemon grassSudanLeaves: hydro-distilled1)α- verbenol (20%)2)transpincarveol (19.41%)3)trans- p-menthe-2,8-dien-ol (14.14)4)d-Limonene (8.49%)The essential oils extract showed Anti-TB activity at 15 μl/ml against nine clinical isolated *M. tuberculosis* strains and H37Rv ([@b0290]).Antifungal ([@b0035]).*Cymbopogen proximus* leavesLemon grassSudanLeaves: hydro-distilled/1)piperitone (43.2, 45.8%)2)elemol (13.45, 14.43%)3)4-carene (7.55, 9.75%)4)β-eudesmol (5.41, 4.32%)The essential oils extract showed Anti-TB activity at 15 μl/ml against nine clinical isolated *M. tuberculosis* strains and H37Rv ([@b0290]).Antibacterial ([@b0815]).Portulacaceae*Portulaca oleracea* L.Moss-roseEgyptHerb: methanol extractMethanol plant extract was active against *M. bovis* BCG at MIC \> 500 μg/ml ([@b0030]).Muscle spasms ([@b0795]).Primulaceae*Cyclamen hederifolium* AitonSowbreadTurkeyAerial & Tuber: ethanol extracts 70%The plant extracts showed Activity against H37Rv 100 μg/ml with 4% & 36% Inhibition, respectively ([@b0905]).Anti-inflammatory ([@b0655]).*Primula vulgaris* Huds. subsp. sibthorpii(Hoffmanns.) W. W. Sm. et ForrestPrimroseTurkeyLeaves & Flower: ethanol extracts 70%At 100 μg/ml, the ethanol extract of both leaves and flower showed 41% inhibition of growth against H37Rv ([@b0905]).NilPunicaceae*Punica granatum* L.AnarIranPeel: maceration method by 70% ethanolPotential activity against all *M. tuberculosis*isolates & H37RV with mean inhibitory zone of 18.8 mm at 200 mg/ml ([@b0495]).Anti-bacterial cold, flu ([@b0390], [@b0495]).*Punica granatum* L.AnarIranPeel: hydro-alcoholic extracts by cold percolation methodThe plant extract showed best effect against *M. bovis* strain at 4 mg/ml with 32 mm inhibition zone ([@b0390]).Anti-bacterial ([@b0390])*Punica granatum* L.AnarTurkeyLeaves & Flower: ethanol extracts 70%At 100 μg/ml, the ethanol extract of both leaves and flower showed 36% inhibition of growth against H37Rv ([@b0905]).Anti-bacterial ([@b0390])*Punica granatum* L.AnarEgyptFruit: methanol extractExhibited activity of plant extract against *M. bovis* BCG at MIC \> 500 μg/ml ([@b0030]).Anti-bacterial ([@b0390])Ranunculaceae*Adonis dentat*DelileEgyptAerial part: maceration with70% methanolExtracts methanol plant showed activity against *M. phlei* at MIC 80 mg/ml & DIZ 25 mm ([@b0785]).Antibacterial agent ([@b0785]).*Nigella sativa* seedsBlack cuminSudanHydro-distillation /1)p-cymene 45.262)Thymoquinone 35.353)1,5-decadiene 9.9The oils extract exhibited anti-TB at 15 μl/ml against nine clinical isolates and H37Rv of *tuberculosis* ([@b0285]).Cough, asthma & cold ([@b0470]).Rhamnaceae*Ziziphus spina*-christi(L.) Willd.JujubeSudanLeaf, Bark: Sonication dichloromethane,ethyl acetate and ethanol (10 mg/ml)The plant parts extract showed result with (MIC) values against *Mycobacterium aurum* A^+^\
Leaf extract 12.5, 12.5 & 6.25 mg/ml\
Bark extract 25, 6.25 & 0.39 mg/ml ([@b0280]).NilRutaceae*Citrus lemon*LimooIranPowder, fresh juice: maceration method by 70% ethanolModerate inhibitory activity only against sensitive (non MDR; non multi drug resistant) strains of *M. tuberculosis* ([@b0495])*.*Cold & fever ([@b0495]).*Citrus lemon*LimooIranPowder: hydro-alcoholic extracts by cold percolation methodThe plant extract showed best activity against *M. smegmatis* strain at 4 mg/ml with 27 mm inhibition zone ([@b0390]).Cold & fever ([@b0495]).*Haplophyllum schelkovnikovii* Grossh.NilTurkeyAerial : ethanol extracts 70%Ethanol extract showed activity against H37Rv at concentrations 100 μg/ml with 24% inhibition ([@b0905]).Antimicrobial ([@b0885]).Salicaceae*Salix babylonica* L.Weeping willowEgyptLeaf: methanol extractThe plant extract was active against *M. bovis* BCG at MIC \> 500 μg/ml ([@b0030]).Antipyretic ([@b0260]).*Salix safsaf* Forsk.Safsaf willowEgyptLeaf: methanol extractMethanol plant extract showed activity against *M. bovis* BCG at MIC \> 500 μg/ml ([@b0030]).Antimicrobial ([@b0465]).Sapindaceae*Koelreuteria paniculata* Laxm.Goldenrain treeTurkeyLeaf: ethanol extractsAt 100 μg/ml, the extract of plant showed 11%\
Inhibition against H37Rv ([@b0905]).NilSapotaceae*Argania spinosa* LArganIraqMixture of argan oil: 1.5% H2O at six different concentrations.Concentration mixture 2.5: 7.5 and 3:7 exhibited good inhibitory effect against 17 MTB clinical isolated with percentage 64.71--82.35% ([@b0075]).Antibacterial ([@b0425])*Argania spinosa* LArganIraqMixture of argan oil 100% and sider extract 62.5 g\\L at eight different concentrationsThe mixture showed good inhibitory effect against 10 MTB clinical isolated at all different concentration during 28 days incubation time (Prof. Dr. Habeeb Sahib Naher1\*, 2014).Antibacterial ([@b0425])Scrophulariaceae*Digitalis. Sp.*AngoshtaneIranLeaf: maceration method by 70% ethanolEthanol extract of plant was active against five isolates MDR & non MDR *M.tuberculosis* ([@b0495]).Antipyretic ([@b0495])*Scrophularia. Cryptophilai* Boiss. & Heldr.FigwortsTurkeyArial part: Me OH extract/1)Cryptophilic acid C2)Chlorogenic acidThe purified compound showed marginal significant activity against H37Rv strain with 45% and 37% inhibition at MICs 100 μg /ml ([@b0880]).Antiprotozoal ([@b0880]).Solanaceae*Atropa belladonna* L.BelladonnaTurkeyArial & fruit : ethanol extracts 70%The plant extract showed activity against H37Rv at concentrations 100 μg /ml with 2% Inhibition of growth ([@b0905]).Nil*Datura stramonium*JimsonweedIranPowder: percolation extraction 80% ethanolThe crude extract was active against *M. bovis* at 375.0 μg/ml ([@b0730]).Analgesic ([@b0730]).*Hyoscyamus niger* L.black henbaneTurkeyArial: ethanol extracts 70%The extract at 100 μg /ml exhibited 8% inhibition against H37Rv ([@b0905]).NilTaxodiaceae*Cryptomeria japonica* (L. fil.) D. Don.Japanese cedarTurkeyLeaves: ethanol extracts 70%The plant ethanol extract was active against H37Rv at concentrations 100 μg /ml with 57% Inhibition of growth ([@b0905]).NilThymelaeaceae*Thymelaea hirsuta* LhirsutaEgyptAerial part: maceration with70% methanolMethanol extract exhibited activity against the *M. phlei M. smegmatis* and *M. tuberculosis* H37Rv with MIC 40, 40 and 62.5 mg/ml with DIZ 22, 20 and10 mm, respectively ([@b0785]).Antibacterial agent ([@b0785]).Ulmaceae*Ulmus glabra* HudsonNilTurkeyLeaves: ethanol extracts 70% and fraction with petroleum ether, chloroform, methanol and waterThe plant extraction and fraction by petroleum ether show inhibited growth at 50 μg/ml MIC against *M. tuberculosis* H37Ra ([@b0900]).NilUrticaceae*Urtica dioica* L.NilTurkeyAerial: ethanol extracts 70% and fraction with petroleum ether, chloroform, methanol and waterThe plant extraction and fraction by petroleum ether exhibited anti-TB activity against *M. tuberculosis* H37Ra at 50 μg/ml MIC ([@b0900]).NilUsneaceae*Usnea barbata* (L.) MottBeard lichenTurkeywhole plant: maceration by ethanol extracts 70%, fractionation by with petroleum ether, chloroform, methanol and water/1)Usnic acidEthanol extract of whole plant exhibited activity against H37Rv at 100 μg /ml.\
The fraction and isolated compound usnic acid as major compound inhibited *M. tuberculosis* H37Rv with Minimum inhibitory concentrations (MICs) at 12.5 µg/ml ([@b0905]).NilVerbenaceae*Vitex agnus-castus* L.Chaste treeTurkeyLeaves & fruit; ethanol extracts 70%The ethanol extracts of both leaves and fruit exhibited Inhibition of growth against H37Rv at 100 μg /ml ([@b0905]).NilVitaceae*Vitis vinifera* L.Common grape vineTurkeyLeaves : ethanol extracts 70%At 100 μg/ml, the extract of plant showed 73%\
Inhibition against H37Rv ([@b0905]).NilZingiberaceae*Curcuma longa* L.TurmericEgyptRoot: methanol extractThe methanol plant extract of plant showed activity against *M. bovis* BCG at MIC \> 500 μg /ml ([@b0030]).Antibacterial ([@b0800]).Zygophyllaceae*Peganum harmala* L.EsphandIranSeed: maceration method by 70% ethanolPotential activity against all *M. tuberculosis* isolates & H37RV with mean inhibitory zone of 18.7 mm at 200 mg/ml ([@b0495]).\
Mean of inhibitory zone was 18.7 ± 3.5 mm at concentration of 200 mg/ml of extract against all *M. tuberculosis* isolates & H37RV.\
TNF-α decrease in production after extract added in human macrophage cell line U937 with infected by H37Rv strain ([@b0240]).Respiratory diseases ([@b0495]).

2. Methodology {#s0010}
==============

This review included all related published scientific articles as illustrated in [Fig. 1](#f0005){ref-type="fig"}. This research was conducted by searching the electronic databases NCBI, Google Scholar, Scopus and Science Direct for relevant studies from the year 2000 to 2018. Relevant studies were reviewed through numerous steps. In the first step, target published articles were identified by using general related terms, such as 'medicinal plants' and 'Middle Eastern and North African area.' The second step involved screening the resulting articles by using highly specific keywords, including 'anti-*Mycobacterium tuberculosis,*' '*in vitro*' and '*in vivo*.' The last step of the review focused on selected studies involving native medicinal plants and their related contributions.Fig. 1Research Process.

3. Bioassay guidance for evaluating anti-TB activity {#s0015}
====================================================

Modern reviews show that the bioassay-guided method is used in TB drug discovery to identify bioactive compounds from natural crude extract(s). This process includes alternating steps to identify the bioactive compounds of natural compounds by using bioassays and chemical fractionation; hence, multiple samples are taken for mycobacteriology--herbal product chemistry analysis ([@b0320], [@b0475]). In recent years, chromatography and spectroscopy techniques have spearheaded technological advancements that have improved the sensitivity of fractionation procedures for natural products and made way for new studies on unknown materials, previously inspected genera and unknown chemical and new bioactive compounds ([@b0705]). Thus, the development of new phytochemical approaches for bioassaying anti-TB drugs is essential to produce highly effective ways of discovering herbal resources. The terminal point must be chosen wisely to present the good orientation of bioassay steps. Bioassay-guided drug discovery has been performed for different medicinal plants, such as *Dracaena angustifolia* and *Premna odorata*, which have yielded numerous potential compounds with antimycobacterial activity ([@b0295], [@b0375], [@b0475]). Additional details are provided in [Table 1](#t0005){ref-type="table"}.

3.1. Target organism {#s0020}
--------------------

In trials for discovering new anti-TB drugs, visible results are obtained by using the actual pathogenic agent MTB. MTB H37Rv (ATCC 27294) is the ideal target organism that is the main source of drug sensitivity in clinical sample isolates. Chemical molecules do not need to check initially when MDR-TB strains are used because these strains exhibit resistance to many drugs on the basis of a simple mechanism that is similar to the effusion pump mechanisms of several bacteria. However, genetic mutation gives rise to resistance to new bioactive compounds with novel mechanisms of action that are starkly different from the action mechanisms of currently used anti-TB drugs ([@b0375], [@b0475]). Given the virulence factors of the pathogenic MTB H37Rv strain, it should be carefully processed in a biosafety level 3 laboratory with specific safety requirements for workers and researchers. Most natural product researchers opt for an avirulent surrogate strain, such as *Mycobacterium smegmatis* (ATCC 607), that has exhibited good growth in many anti-TB studies ([@b0675], [@b0785]). Other researchers use a non-pathogenic strain, such as MTB H37Ra (ATCC 25177), and vaccine strains, such as *Mycobacterium bovis* BCG (ATCC 35743) ([@b0030]). All of the above-mentioned strains are closely related to the virulent MTB H37Rv strain in terms of drug susceptibility and genetic material. Working with these kinds of strains requires a class 2 biosafety cabinet ([@b0375], [@b0675]). Additional details are listed in [Table1](#t0005){ref-type="table"}.

3.2. *In vitro* methods for evaluation of anti-TB drugs {#s0025}
-------------------------------------------------------

### 3.2.1. Agar diffusion {#s0030}

The disc-and-well diffusion assay is a common method used for the evaluation of different antimicrobial agents. The capability of a natural resource to inhibit bacterial growth at an unknown concentration is screened on the basis of the length of a concentration gradient; however, this approach is insufficiently quantitative for the estimation of natural extracts and products or new crude materials. The size of the inhibition zone is a sign of microbial susceptibility or resistance to well-characterised antibiotics and can be used to calculate the mean diffusion rate of an active compound and the ratio of microbial growth ([@b0705]). Given that MTB has a cell wall with a high lipid content and that is composed of a hydrophobic area that is susceptible to less-polar compounds, its use in agar diffusion assays is not recommended ([@b0805]). On aqueous agar, the faster diffusion rate of polar compounds than that of nonpolar compounds with identical molecular weights results in the formation of small inhibition zones and the wrong impression of weak product activity. Furthermore, active polar compounds with low molecular weight may diffuse to equilibrium before the growth of slow-growing mycobacterial colonies. In this case, a zone of inhibition is absent because the concentration of the compound is below the minimum inhibitory concentration at equilibrium ([@b0705], [@b0805]). Extracts of *Peganum harmala* L exhibit potential activity against all clinical MTB isolates and the H37RV strain with a mean inhibitory zone of 18.7 mm at 200 mg/ml ([@b0495]).

### 3.2.2. Micro and macro agar dilution {#s0035}

The activities and minimal inhibitory concentrations (MICs) of new natural plant extracts with known concentrations, fractions or materials can be quantified and evaluated in agar media. Except for many fastidious organisms, most mycobacterial strains, such as MTB, tend to produce active colonies on Middlebrook 7H10 or 7H11 agar media, which comprise oleic acid, albumin, dextrose and catalase ([@b0375]). The sample to be tested can be added to the semisolid media at 1% v/v final concentration and then, 100--200 µl, 4 ml, 1.5 ml and 20 ml of media are added to 96-well, 6-well, 24-well microplates or 150 mm diameter petri dishes, respectively. Once the agar has solidified, the inoculum is dropped on the medium surface by using a micro pipette. Then, 100 µl of inoculum is spread on Petri dishes, 10 µl of inoculum is spread on 6- or 24-well plates and 1--5 µl of inoculum is spread on 96-well plates. Incubated plates are kept overnight at 37 °C, and the plates should be inverted for the remaining incubation period. The major weakness of such a bioprocedure is that approximately a minimum of 18 days is needed for the visible growth of *Mycobacteria* colonies ([@b0375], [@b0675]).

### 3.2.3. Micro-broth dilution {#s0040}

Small amounts of samples are required when evaluating the activities of natural products in 96-well microplates. This technique offers advantages, such as reduced cost, good overall production and automated process. The mycobacterial organism is usually cultured in Middlebrook 7H9 broth with the addition of 0.5% glycerol, 0.1% casitone, 0.05% Tween-80 and ADC (10%). The quantitative evaluation of many mycobacterial strains in liquid medium based on turbidity caused by clumping behaviour is difficult ([@b0705]). The use of alamarBlue dye indicator accelerates this technique and increases its sensitivity ([@b0805]). The results of this method can be read visually without requiring any tools. The reduction of alamarBlue can be estimated by using a colorimeter and then subtracting the absorption measured at 600 nm from that measured at 570 nm. The microbroth dilution technique can be applied by using either resazurin or tetrazolium dye to obtain results with increased sensitivity ([@b0620]). Hence, the results for partial inhibition can be obtained via high-throughput anti-TB assays by using a microplate spectrophotometer or fluorometer, making these methods perfect for determining the various activities of crude natural products at different concentrations ([@b0805]).

3.3. Anti-TB *ex vivo* bioassay {#s0045}
-------------------------------

The efficacies of plant natural extracts against many microorganisms and mycobacterial organisms can be profiled by using *ex vivo* models. Isolated peripheral blood mononuclear cells (PBMCs) from patients suffering from tubercular disease are an actual *ex vivo* model. The evaluation of natural compound extracts can be improved when performed on samples collected from patients with different severities of disease infection induced by various mycobacterial strains (MDR-TB or XDR-TB). Animal models provide a different immune pathological situation. For example, animal cells infected with mycobacterial strains from patients produce nitric oxide compounds that are different from those produced by noninfected animal cells ([@b0830], [@b0935]). The variation in gene expression in animal models accounts for the difference between plant extract activity in isolated infected PBMCs and that in noninfected PMBCs. Hence, *ex vivo* bioassays based on PMBCs for testing novel anti-TB material are more knowledge-based and less expensive than *in vivo* animal models ([@b0675]).

3.4. *In vivo* evaluation for anti-TB drugs {#s0050}
-------------------------------------------

The final drug candidate for clinical evaluations must be tested at different dosages that are well tolerated in humans by using *in vivo* animal models with mycobacterial infections. Mice are exposed to virulent mycobacterial strains via aerosol; this exposure route leads to a low level of MTB accumulation in lung tissues ([@b0325], [@b0705]). After the cellular growth of tubercule bacilli and host immune response, therapy steps are applied through two phases: the rapid multiplication phase (up to 1 month) and the latent phase, which may last for several months ([@b0255], [@b0325]). *In vivo* methods can be used to evaluate the activity of extracted natural products during the latent stages of infection ([@b0340], [@b0590]). The extracts of all leaf parts and young stems and flower oils of *P. odorata* have clear anti-TB activities against \>1.5 μg/ml MTB antigen with the MIC of 100 μl/ml *in vitro* and 300 μl/ml *in vivo* ([@b0295]).

4. Molecular and protein studies for TB agent {#s0055}
=============================================

This review included all of the microbial genetic content of genomics studies based on genome sequencing and bioinformatics analysis to reveal potential specific active targets for antigen discovery and support the production of known antibacterial agents and new vaccine strains. The first TB study was carried out on the MTB H37Rv strain. This study showed the attribution of specific functions (∼40% of 4000 genes). Once information was available for active genes, the exact target drug was determined on the basis of its proposed metabolic production pathway ([@b0345]). Gene expression analysis may represent a helpful tool for achieving three goals in drug discovery: (i) determining specific targets, (ii) studying antibiotic activity and (iii) proposing new types of bioassays ([@b0345], [@b0570]). Extensive variations in genomic molecular targets lead to the different results of anti-TB drugs, and novel molecules should inhibit the active genes involved in the bacterial life cycle ([@b0975]). Protein production is the last step in the molecular gene process. DNA chip technology is overcoming the problems of protein production, which can be considered as a key factor in antimycobacterial drug discovery ([@b0570]). Approximately 263 proteins from *M. bovis* BCG and MTB strains have been determined through two-dimensional gel electrophoresis coupled with mass spectrometry. This protein analysis technique provides good results with the assistance of whole-genome sequence databases ([@b0565], [@b0940]). Different mechanisms that interrupt bacterial biosynthetic pathways, such as protein, cell wall and DNA synthesis pathways, are considered in the discovery of antitubercular agents with specific targets ([@b0615]).

5. MENA region medicinal plants with potential feature of anti-TB activity {#s0060}
==========================================================================

The search results for literature on medicinal plants with anti-TB activity from the MENA region revealed few studies. The climates and traditional medicinal plants of the countries in the MENA region vary. Given the abundant biodiversity and traditional ethnomedicines available in the MENA region, a massive potential for preparing a dedicated programme for tuberculosis treatment exists.

This review included medicinal plants from different families exhibiting anti-TB activities. [Table 1](#t0005){ref-type="table"} shows information on these medicinal plants, including plant family, scientific name, country of origin, mode of preparation/active compound, mode of action (MIC value) and traditional uses. These plant species have different ethnomedical uses. A total of 184 plants species representing 73 families and 165 plants species (88%) show good correlations with treatment of TB or signs of respiratory disease, such as coughing, pulmonary infections, asthma and bronchitis ([Table 1](#t0005){ref-type="table"}). A total of 93 plant species accounted for 51% of the active compounds against MTB (crude extracts and/or bioactive compounds with MICs of 0--\<100 µg/ml).

These plant species are *Alyssum fulvescens* Sibth. et Sm. var. fulvescens., *Anchusa azurea* Miller var. azurea., *Atropa belladonna* L., *Bougainvillea glabra* Choisy., *Calystegia silvatica* (Kit.) Griseb., *Centaurea depressa* Bieb., *Cerinthe minor* L. auriculata (Ten.) Domac., *Cheiranthus cheiri* L., *Cistus laurifolius* L., *Clinopodium vulgare* L. subsp. arundanum (Boiss.) Nyman., *Crocus ancyrensis* (Herbert) Maw., *Cryptomeria japonica* (L. fil.) D. Don., *Elaeagnus angustifolia* L., *Echinops pungens* Trautv., *Echium plantagineum* L., *Echium italicum* L., *Epilobium angustifolium* L., *Eremostachys laciniata* (L.) Bunge., *Erysimum cuspidatum* (Bieb.) DC., *Ficus carica* L. subsp. carica., *Geranium asphodeloides* Burm. Fil., *Geranium divaricatum* Ehrh., *Geranium robertianum* L., *Glaucium leiocarpum* Boiss., *Haplophyllum schelkovnikovii* Grossh., *Helianthus annuus* L, *Helichrysum plicatum* DC. subsp. pseudoplicatum (N;ab.), *Heliotropium dolosum* De Not., *Hibiscus syriacus* L., *Hypericum triquetrifolium* Turra*., Hyoscyamus niger* L., *Inula helenium* L. subsp. turcoracemosa., *Inula peacockiana* (Aitch. et Hemsl.) Krovin., *Inula peacockiana* (Aitch. et Hemsl.) Krovin., *Jasminum officinale* L., *Juglans regia* L., *Koelreuteria paniculata* Laxm., *Lamium purpureum* L., *Laurus nobilis* L., *Lavandula stoechas* L. subsp. cariensis (Boiss.) Rozeira., *Lepidium vesicarium* L., *Liriodendron tulipifera* L., *Magnolia grandiflora* L., *Mahonia aquifolium* (Pursch.) Nutt., *Morus alba* L., *Marrubium parviflorum* Fisch. et Mey. subsp. *oligodon* (Boiss.) Seybold., *Mentha longifolia* (L.) Hudson subsp. longifolia., *Morina persica* L., *Myosotis olympica* Boiss., *Onopordum anatolicum* (Boiss.) Eig., *Phlomis lunariifolia* Sm., *Picea orientalis* (L.) Link., *Pinus nigra* Arn.ssp. *pallasiana* (Lamb.) Holmbae., *Primula vulgaris* Huds. subsp. sibthorpii (Hoffmanns.) W. W. Sm. et Forrest., *Punica granatum* L., *Raphanus raphanistrum* L., *Rosmarinus officinalis* L., *Saliva. kronenburgii* Rech., *Scrophularia. Cryptophilai* Boiss. & Heldr., *Sedum stoloniferum* Gmeli., *Sideritis libanotica* Labill. subsp. linearis (Bentham) Bornm., *Silene arguta* Fenzl., *Silene chlorifolia* Sm., *Silene dichotoma* Ehrh. subsp. sibthorpiana (Reichb.) Rech., *Silene vulgaris* (Moench) Garcke var. commutata (Guss.) Coode et Cullen., *Spinacia oleracea* L., *Tripleurospermum conoclinium* (Boiss. et Ball.) Hayek., *Teucrium parviflorum* Schreber., *Usnea barbata* (L.) Mott., *Veratrum album* L., *Vitex agnus-castus* L and *Vitis vinifera* L.

*Boswellia papyrifera* (Del) Hochst olibanum*, Chelidonium majus* L, *Cymbopogen citratus, Cymbopogen nervatus* inflorescences, *Cymbopogen proximus, Eucalyptus camaldulensis, Inula helenium* L. subsp. *turcoracemosa, Khaya senegalensis, Micromeria juliana, Nigella sativa, Pinus brutia* Ten, *Premna odorata, Rosmarinus officinalis*, *Salvia aethiopis* L, *Satureja aintabensis, Stachys sylvatica* L, *Thymus sipthorpii*, *Thymus vulgaris, Ulmus glabra* Hudson, *Urtica dioica* L, *Usnea barbata* (L.) Mott and *Veratrum album* L. are widely distributed in the MENA region and have been proven to contain potential agents against MTB. The bioactive compounds extracted from these plant materials have significant *in vitro* activity. Specifically, their extracts have MICs of 1--50 µg/ml.

The oil extracts of *B. papyrifera* (Del) Hochst olibanum contained octyl acetate, octyl formate, verticilla-4(20), 7,11-triene and diterpenes exhibit activity against H37Rv with the MIC of 15 μl/ml. This activity may be attributed to octyl acetate (37.26%) and diterpene constituents (20%) given that different diterpenes extracted from various plants exert activity against MTB by acting as an efflux pump inhibitor ([@b0505], [@b0845]). The ethanol extraction and fraction of *C. majus* L. by petroleum ether and chloroform have inhibited growth at 50 μg/ml MIC against *M. tuberculosis* H37Ra. Essential oils and fractions containing citral b, citral a and β-pinene from *C. citratus* leaves show anti-TB activity with the MIC of 15 μl/ml. α-Verbenol (20%), transpincarveol, trans- p-menthe-2,8-dien-ol and d-limonene have been isolated from the essential oil of *C. nervatus* inflorescences and presented activity against MTB strains with the MIC of 15 μl/ml. The active compounds isolated from *C. proximus* leaves are piperitone, elemol, 4-carene and β-eudesmol. The essential oils of this plant showed anti-MTB activity with the MIC of 15 μl/ml. All essential oils obtained from the genus *Cymbopogon* have clear antitubercular activity because they contain terpenoids, which likely disrupt the lipid layers and permeability of the microbial plasma membrane ([@b0200], [@b0550]).

1,8-Cineole (74.814%), p-cymene and β-phellandrene have been isolated from *E. camaldulensis* Dehnh leaves; the oil extract of this material exhibits activity against H37Rv with the MIC of 15 μl/ml and contains high amounts of compounds, such as oxide 1,8-cineole (75%), showing biological activities and growth inhibition against mycobacterial strains ([@b0095], [@b0580]). The fractionation of *I. helenium* L. subsp. *turcoracemosa* and isolated alantolactone bioactive compound have been screening against *M. tuberculosis* H37Rv with Minimum inhibitory concentrations (MICs) at 3.125 µg/ml. *K. senegalensis*(Desr.) A. Juss. fractions extract by chloroform ethanol, ethyl acetate and n-butane exhibited MIC value at 6.25 μg/ml against MTB H37Ra.

*M. juliana* exhibits activity against four strains of *M. tuberculosis* with the MIC of 12.5--100 μg/ml and the fractions by ethyl acetate showed activity against *M. tuberculosis* H37Rv and H37Ra with MIC of 100 and 50 μg/ml respectively, depended on the quaintity of phenolic compound such as rosmarinic acid, chlorogenic acid, rutin hydrate and caffeic acid were investigated as active compound. P-cymene, thymoquinone and 1,5-decadiene have been isolated from *N. sativa* seeds at concentrations of 45.26%, 35.35% and 9.9%, respectively. The oil extracts of these compounds exhibit activity against H37Rv with the MIC of 15 μl/ml. Anti-TB activity is attributed to the bioactive compound thymoquinone, which has numerous biological activities ([@b0740]). *P. brutia* Ten. ethanol extraction and fraction by petroleum ether exhibited MIC value at 50 μg/ml against *M. tuberculosis* H37Ra. Trans-caryophyllene, β-phellandrene and α-pinene have been identified as bioactive compounds with anti-TB activities from the flower oils and leaf and young stem extracts of *P. odorata* with MIC \> 1.5 μg/ml at the dose of 100 μl/ml *in vitro* and 300 μl/ ml *in vivo*. Anti-TB activity can be attributed to the high content of terpene compounds, such as α-pinene (38.160%) ([@b0315]).

The fractions of *R. officinalis* by n-hexane and chloroform exhibited MIC value 6.25 μg/ml against MTB H37Ra. *Salvia aethiopis* L. ethanol extraction and fraction by petroleum ether and chloroform exhibited MIC value at 50 μg/ml against *M. tuberculosis* H37Ra. *S. aintabensis* presents activity against four strains of *M. tuberculosis* with the MIC of 12.5--100 μg/ml and the petroleum ether fractions showed activity against *M. tuberculosis* H37Rv and H37Ra with MIC of 25 and 50 μg/ml respectively. The ethyl acetate fractions exhibited MIC value of 12.5 μg/ml against *M. tuberculosis* H37Rv and H37Ra, respectively. The strong properties due to present high quaintity of phenolic compound such as rosmarinic acid, naringenin, hesperidin, luteolin, caffeic acid were investigated. The ethanol extraction for *S. sylvatica* L and fraction by petroleum ether showed MIC value at 50 μg/ml against *M. tuberculosis* H37Ra.

*T. sipthorpii* exerts activity against four strains of *M. tuberculosis* with the MIC of 12.5--100 μg/ml and the petroleum ether fractions exhibited MIC values of 12.5 and 50 μg/ml against *M. tuberculosis* H37Rv and H37Ra, respectively. The ethyl acetate fractions showed activity against *M. tuberculosis* H37Rv and H37Ra with MIC of 12.5 μg/ml. The anti-TB properties could depend on the high content of phenolic compounds such as rosmarinic acid, caffeic acid were investigated. The essential oil extracts of *T. vulgaris* exhibited strong activity against clinical isolate *M. tuberculosis* and H37Rv stander strain at MIC value ≤40 μg/ml. Carvacol compound is consider important source from thyme oil will lead to the penetration and distraction cell membrane of bacteria. *U. glabra* Hudson & *U. dioica* L. ethanol extraction and fraction by petroleum ether exhibited MIC value at 50 μg/ml against *M. tuberculosis* H37Ra. From *U. barbata* (L.) Mott. usnic acid was isolated as major compound have been screening with exhibited MIC value at 12.5 µg/ml against *M. tuberculosis* H37Rv. Alkaloid major compound fraction of *V. album* L by chloroform and jervine isolated bioactive compound showed MICs value 50 and 25 μg/ml respectively, against *M. tuberculosis* H37Rv strain. Thus, the bioactive compound extracts of these plant species may be potentially useful against TB and are potential sources of new anti-TB drugs.

Lamiaceae is a plant family from the MENA region with potential anti-TB activity. It contains 48 different plant species that have been tested against TB. Amongst all medicinal plant families, the Lamiaceae plant family has received considerable attention from researchers because they contain different bioactive compounds and are easily soluble in various solvents, including methanol, ethanol and water ([@b0645]). Hydro-distilled extracts and fraction from the leaves, long stems and flowers of *P. odorata, B. papyrifera, E. camaldulensis, I. helenium, K. senegalensis, N. sativa* seeds *R. officinalis* and genus *Cymbopogon* exhibit the highest number of activities against TB.

In the MENA region, Turkey has the highest number of plant species (92) with anti-TB potential because this country possesses the richest plant biodiversity in the temperate zone and approximately 10,000 species of vascular plants ([@b0420]). Turkey has the highest levels of plant biodiversity in the temperate zone and the Mediterranean basin ([@b0810]). The high terrestrial and plant biodiversity of the MENA region may be attributed to its diverse water resources and climates that range from temperate to subtropical ([@b0960]). The unique biodiversity of the MENA region provides considerable possibilities for finding new anti-TB candidates from medicinal plants.

6. Conclusion {#s0065}
=============

Natural pharmaceutical products are used worldwide because of the numerous side effects of chemical drugs. [Table 1](#t0005){ref-type="table"} presents numerous plants that demonstrate active properties against MTB. These plants originate from the MENA region and are members of a wide range of families and species. Their effectiveness has been clearly proven through laboratory tests. Moreover, different compounds have been isolated from these plants. 22 plant species with significant effect with the MIC of ≤50 µg/ml are distributed in the MENA region. They can be used for the synthesis and manufacture of pharmaceutical products in the future. Researchers have attempted to extract crude and bioactive compounds from these plants to develop novel anti-TB drugs. The findings of previous studies may help researchers select plants, such as *I. helenium, K. senegalensis, P. odorata* and *R. officinalis* that contain diverse pharmacological active compounds, and investigate different mechanism that can be used as supportive anti-TB drugs. Therefore, efforts should be made to further investigate and identify the anti-TB activities and toxic constituents of the plants identified in this review.
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